tiprankstipranks
Trending News
More News >
Sagimet Biosciences, Inc. Class A (SGMT)
NASDAQ:SGMT
US Market

Compare Sagimet Biosciences, Inc. Class A (SGMT) vs. Competitors

Compare
1,690 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Sagimet Biosciences, Inc. Class A
$4.82
$149.43M
-3.75
19.01%
8 Buy
1 Hold
0 Sell
Strong Buy
Codexis
$1.60
$145.39M
-3.23
-37.25%
2 Buy
1 Hold
0 Sell
Moderate Buy
Cabaletta Bio
$2.94
$283.02M
-1.33
68.00%
3 Buy
0 Hold
0 Sell
Strong Buy
Black Diamond Therapeutics
$2.11
$120.88M
6.18
12.23%
4 Buy
0 Hold
0 Sell
Strong Buy
Atea Pharmaceuticals
$5.66
$450.94M
-1.84
79.68%
2 Buy
1 Hold
0 Sell
Moderate Buy
Entrada Therapeutics Inc
$11.31
$433.00M
-2.96
8.65%
6 Buy
0 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
SGMT
Sagimet Biosciences, Inc. Class A
4.82
0.69
16.71%
CDXS
Codexis
1.60
-1.47
-47.88%
CABA
Cabaletta Bio
2.94
1.22
70.93%
BDTX
Black Diamond Therapeutics
2.11
0.43
25.60%
AVIR
Atea Pharmaceuticals
5.66
2.46
76.88%
TRDA
Entrada Therapeutics Inc
11.31
0.51
4.72%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts